Recently, new evidence points out that the RAS is a driving force for the development of IH, and the vasoactive peptide angiotensin II (ATII) is considered as a key regulator of the hemogenic endothelium (26, 27). The gene discussed is AGT; the disease is isolated hemihyperplasia.